Clinical Trial Update: Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated the safety and pharmacokinetics of S-707106 administered alone and in combination with open-label metformin in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• S-707106
• metformin (metformin)

Snippet

Sponsor: Shionogi | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED